About this trial
The purpose of this research study is to examine the role oxidants, substances produced in the blood that can damage blood vessel function, may play in blood vessel function in healthy individuals as well as individuals with mental health disorders (posttraumatic stress disorder (PTSD) and/or generalized anxiety disorder (GAD)).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
apparently healthy and free of overt cardiovascular, pulmonary, or metabolic disease
for PTSD group, a score of ≥ 33 on PCL-5 checklist
for GAD group, a score of ≥ 10 on the GAD-7 self-report scale and < 33 on the PCL-5 checklist
for Healthy Control group, a score of ≤ 10 on the GAD-7 self-report scale and < 33 on the PCL-5 checklist
Disqualifiers
taking medications that could influence cardiovascular function
current smokers who have recently quit smoking
illicit drug use or excessive alcohol consumption
pregnant women
Trial design
Crossover
Treatments tested in this trial
Antioxidant
Dietary supplementSubjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol).
Placebo
Dietary supplementSubjects will ingest placebo (microcrystalline cellulose) pills.
Treatment groups
Trial outcomes
Primary outcomes
Arm Vascular Function at Rest (Flow Mediated Dilation Test)
Change in Brachial Artery Dilation from Baseline Values
Leg Vascular Function (Passive Leg Movement Test)
Change in Leg Blood Flow Values from Baseline
Arm Vascular Function in Response to Exercise (Handgrip Exercise Test)
Change in Brachial Artery Dilation from Baseline Values
Sponsors and contacts
Click on the lead sponsor to view all of their trials.